Concepedia

Faranak Azarbayjani

FA

14

Publications

560

Citations

14

H-Index

1997

Active since

Affiliations

Uppsala University(Current)

Uppsala University Hospital

AstraZeneca (Sweden)

Karolinska Institutet

AstraZeneca (United Kingdom)

Faranak Azarbayjani is an author at Uppsala University specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

1997–2024

14

Publications

14

The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma Xenografts

Lova Segerström, D. Fuchs, Ulrika Bäckman et al. · Pediatric Research · 2006 · 94 citations · Full text

, , +7

Initiation of phenytoin teratogenesis: Pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation

Bengt Danielsson, Faranak Azarbayjani, A.-C. Sköld et al. · Teratology · 1997 · 63 citations

Digoxin inhibits neuroblastoma tumor growth in mice.

Åsa Svensson, Faranak Azarbayjani, Ulrika Bäckman et al. · PubMed · 2005 · 63 citations

Embryonic Arrhythmia by Inhibition of HERG Channels: A Common Hypoxia‐related Teratogenic Mechanism for Antiepileptic Drugs?

Faranak Azarbayjani, Bengt Danielsson · Epilepsia · 2002 · 58 citations

Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: A common teratogenic mechanism for antiepileptic drugs?

Faranak Azarbayjani, Bengt Danielsson · Teratology · 1998 · 54 citations

Rows per page

1–5 of 14